Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-12-253418
Filing Date
2012-05-30
Accepted
2012-05-30 16:04:07
Documents
5
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT NO. 2 d360757d10ka.htm 10-K/A 164476
2 SETTLEMENT AGREEMENT AND RELEASE d360757dex1051.htm EX-10.51 29486
3 CERTIFICATION OF THE CEO PURSUANT TO SECTION 302 d360757dex311.htm EX-31.1 4197
4 CERTIFICATION OF THE CAO PURSUANT TO SECTION 302 d360757dex312.htm EX-31.2 4365
5 CERTIFICATION OF THE CEO AND CAO, PURSUANT TO 18 U.S.C. SECTION 1350 d360757dex321.htm EX-32.1 6102
  Complete submission text file 0001193125-12-253418.txt   209871
Mailing Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34810 | Film No.: 12877755
SIC: 2835 In Vitro & In Vivo Diagnostic Substances